PT S Test Strips and Controls for The Coaguchek S System, Models 2032422 and 3271404
Test, Time, Prothrombin. 510(k) K020831, from Roche Diagnostics Corp. (Indianapolis, IN). Product code GJS, class 2.
As of Nov 19, 2026, K020831 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Oct 24, 2002 after 224 days, with no recalls tied to it in FDA's recall database.
- Review time: 224 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The CoaguChek S System is intended for quantitative Prothombin Time (PT) testing for monitoring of warfarin therapy, using fresh capillary or non-anticoagulated venous whole blood by professional health care providers.
- Protime Microcoagulation System / Protime 3 CuvetteK010599 · International Technidyne Corp. · Jul 2, 2001
- Smartcheck Inr SystemK071265 · Inverness Medical Innovations, Inc. · Nov 30, 2007
- Coaguchek XS SystemK060978 · Roche Diagnostics · Aug 11, 2006
- CoaguChek XS Plus SystemK253188 · Roche Diagnostics · Oct 24, 2025
- microINR SystemK251564 · Iline Microsystems, S.L. · Jul 21, 2025
- microINR SystemK243543 · Iline Microsystems, S.L. · Feb 27, 2025
- i-STAT PTplus Cartridge with the i-STAT 1 SystemK220282 · Abbott Laboratories · Jul 14, 2023
- microINR SystemK231711 · Iline Microsystems, S.L. · Jul 11, 2023
- STA- NeoPTimalK211485 · Diagnostica Stago S.A.S · Dec 23, 2022
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingK212779 · Coagusense, Inc. · Oct 5, 2022
- HemosIL ReadiPlasTinK213426 · Instrumentation Laboratory CO · Aug 16, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 14, 2002
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7750
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files